Description
Sex, gender, and sexual orientation significantly impact our disease risk, healthcare access, health outcomes, and overall health and well-being. In Canada, Two-Spirit, lesbian, gay, bisexual, transgender, gender diverse, queer, questioning, intersex, and other gender and sexual minority (2S/LGBTQI+) communities now represent over 1.3 million people – approximately 4.4% of the population – yet continue to experience persistent and systemic health inequities.1 These health inequities are rooted in the social and structural determinants of health, including stigma and discrimination, limited access to affirming and inclusive health care, and erasure in research, data and policy practices.
While sexually and gender-diverse people are more visible and vibrant than ever before, health research focused on 2S/LGBTQI+ health priorities and needs has not kept pace. This lack of research investment limits opportunity for the development and implementation of evidence-informed care and policies. In Canada, most health research funding for 2S/LGBTQI+ health has supported research on sexually transmitted and blood-borne infections (STBBIs), particularly HIV.
2 These research investments have yielded tremendous advancements in STBBI prevention, treatment, and care, and emerging evidence highlights the need and opportunity for impactful research on broader health priorities affecting 2S/LGBTQI+ individuals and communities, extending well beyond STBBIs.
For instance, trans adults have 40% higher risk of cardiovascular disease compared to cis adults.
3 Lesbian and bisexual women face elevated risks for heart disease, cancer, asthma, and arthritis relative to heterosexual women.4,5,6 Chronic pain and mental health challenges are disproportionately high among 2S/LGBTQI+ individuals, especially among youth, older adults, and those experiencing homelessness.1,7,8 Inequities extend to engagement in healthcare services, with 2S/LGBTQI+ individuals more likely to avoid engaging with primary care and have greater unmet healthcare needs than non-2S/LGBTQI+ individuals due
9 – in part – to fears of discrimination, past negative care-seeking experiences, and/or lack of trust in the health system.10 These barriers are compounded by a lack of provider training and affirming care models, particularly for those living in rural areas, navigating disability-related access needs, and/or facing racism within and outside of 2S/LGBTQI+ communities.11,12
Importantly, inequities in health outcomes and access to care may be further compounded by intersecting forms of marginalization, including racism, ableism, colonization, and poverty, underscoring the need for intersectional frameworks and analyses that recognize the diversity, resilience, and strengths within 2S/LGBTQI+ communities.13,14 These frameworks are essential for understanding how multiple systems of oppression interact, and for guiding research and policy that is responsive to the lived and living experiences of those most impacted.15
Despite these challenges, emerging evidence also highlights areas of strength and resilience within 2S/LGBTQI+ communities. For example, access to gender-affirming care – including hormone therapy and mental health supports – has been shown to significantly improve mental health outcomes for trans and gender-diverse individuals, including reductions in depression, anxiety, and suicidality.16,17
Across Canada, there is an urgent demand and need for increased investment in 2S/LGBTQI+ health research that is inclusive, community-led, and equity-focused across the four pillars of health research. The documented rise in harmful anti-2S/LGBTQI+ movements18 risks intensifying health inequities and threatening the health, safety, and well-being of 2S/LGBTQI+ individuals and communities. This funding opportunity calls for bold research proposals that centre lived and living experience and community priorities to generate robust scientific evidence necessary to transform and advance 2S/LGBTQI+ health through research.
Purpose
The overall purpose of this funding opportunity is to advance, strengthen, and enhance inter-disciplinary, high-impact, and community-engaged health research that addresses the health priorities of 2S/LGBTQI+ individuals and communities in Canada.
As we continue to advance 2S/LGBTQI+ health research, several critical gaps must be addressed. This includes the need for studies that directly confront the limitations of existing epidemiological evidence – particularly given that much of the current data is mixed, inconclusive, or not rooted in Canadian contexts. To better understand the root causes of health inequities, mechanistic studies are needed to explore the specific pathways through which these inequities emerge and persist. Strengthening research methodologies and improving measurement tools will be essential to generate more rigorous and actionable evidence. Importantly, this funding opportunity emphasizes the need to move beyond simply including 2S/LGBTQI+ populations in broader studies toward research that is intentionally designed to centre the unique experiences, perspectives, and priorities of 2S/LGBTQI+ people.
A wide range of research approaches are eligible, including community-based and participatory research, Indigenous methodologies, epidemiological studies, clinical studies, health systems research, biomedical research, economic and policy analyses, population-based cohort studies, comparative and measurement studies, and health surveillance. Interdisciplinary research is encouraged, drawing from fields such as biomedical science, public and population health, health systems and services, gender and health studies, Indigenous (First Nations, Inuit, and/or Métis) health, Artificial Intelligence (AI) disciplines, sociology, anthropology, political science, and more. Both original and synthesis research are supported.
Equity, Diversity, and Inclusion
All proposals must apply an equity-focused lens in their design and analysis, where relevant. A particular focus should be in relation to the social determinants of health to assess how both biological and sociocultural factors such as sex, gender, age, race, ethnicity, socioeconomic status, disability, sexual orientation, cultural background, migration status, and geographic location interact and intersect with each other to impact 2S/LGBTQI+ individuals and communities. Refer to the Best practice in Equity, Diversity and Inclusion in Research for additional guidance.
First Nations, Inuit, and Métis
Taking a rights-based and distinctions-based approach to Indigenous self-determination in research is important to reflect the unique position of First Nations, Inuit, and Métis as distinct, rights-bearing communities. This approach strengthens Indigenous health and well-being by acknowledging the specific histories, cultures, and needs of First Nations, Inuit, and Métis Peoples. CIHR's commitment to supporting Indigenous self-determination in health research is available in the CIHR Strategic Plan 2021–2031 and the Action Plan: Building a healthier future for First Nations, Inuit, and Métis Peoples.
Research Topics
This Funding Opportunity seeks to move beyond descriptive analyses. Possible topics or project themes might include, but are not limited to:
Priority Research Topics
Communities of Focus
Research Approaches
Funds Available
CIHR and partner(s) financial contributions are subject to availability of funds. Should CIHR or partner(s) funding levels not be available or decrease due to unforeseen circumstances, CIHR and partner(s) reserve the right to reduce, defer or suspend financial contributions to grants received as a result of this funding opportunity.
CIHR reviewers heavily weight methodological rigor, including:
Strong theoretical framework
Clear hypotheses or research questions
Robust study design
Adequate controls, power calculations, and statistics
Reproducibility & transparency practices
Clear milestones and contingency plans
Predictor: Methodological strength is the #1 determinant across all CIHR committees.
CIHR prioritizes research that benefits:
The health of people living in Canada
Canadian healthcare systems and policies
Vulnerable or underserved populations
Chronic disease burdens in Canadian demographics
Predictor: Clear articulation of Canadian relevance dramatically improves scores.
Successful CIHR proposals:
Have 2–3 well-defined aims
Present realistic deliverables within the grant period
Include detailed methodologies for each aim
Avoid overambitious or unfocused scope
Demonstrate precise timeline and project management
Predictor: Feasibility + clarity of approach = high reviewer confidence.
Reviewers value:
Publications relevant to the field
Prior successful funding
Expertise aligned to each aim
Multi-disciplinary teams (clinicians, statisticians, biomedical scientists, policy experts)
For early-career investigators: mentorship, protected time, and institutional support
Predictor: A well-matched, credible team is essential.
Highly competitive CIHR proposals commonly include:
Pilot experiments or feasibility data
Retrospective analyses
Early mechanistic insights
Proof-of-concept findings
For high-risk or exploratory programs, strong rationale can substitute, but evidence is still preferred.
Predictor: Preliminary data significantly boosts chances.
CIHR explicitly evaluates EDI in:
Team composition
Training environment
Research design (sex, gender, intersectionality, inclusive sampling)
Barriers to participation or recruitment
Engagement with under-represented or Indigenous populations
Predictor: Meaningful EDI integration is essential; weak EDI sections lower scores.
CIHR places high value on:
How findings will reach clinicians, policymakers, communities, or the public
Realistic KT activities (briefs, publications, engagement, partnerships)
Integrated knowledge translation when applicable (co-design with stakeholders)
Predictor: Strong KT plan with defined stakeholders and products.
High success when aligned with:
Indigenous health
Digital health & AI
Aging and dementia
Chronic disease (cancer, cardiovascular, neurological)
Rare disease
Implementation science
Mental health, substance use
Health system strengthening
Predictor: Direct strategic alignment increases competitiveness.
CIHR reviewers look for feasibility evidence:
Confirmed clinical recruitment sites
Existing cohort or biobank access
Computational / lab infrastructure
Letters of support verifying data access
Agreements for collaboration or sharing
Predictor: Proven resource availability reduces perceived risk.
Successful budgets:
Are lean and proportional to aims
Avoid unnecessary equipment or inflated salaries
Align with Canadian Tri-Council rules
Include justification for trainees, supplies, analyses
Predictor: A clear, efficient budget strengthens feasibility.
| Pitfall | Why It Hurts |
|---|---|
| Vague or overly ambitious aims | Feasibility concerns |
| Weak or missing preliminary data | Too speculative |
| Poor methodology or unclear analytic plan | Low rigor |
| Minimal relevance to Canadian health | Weak significance |
| Poor EDI integration | Fails mandatory criteria |
| No KT or weak dissemination plan | Low potential impact |
| Unclear roles of team members | Execution risk |
| Overinflated budget | Reviewer concerns |
For an application to be eligible, all the requirements stated below must be met:
Eligible Countries:
Sponsor Institute/Organizations: Canadian Institutes of Health Research
Sponsor Type: Corporate/Non-Profit
Address: 234 Laurier Ave West, Ottawa, ON K1A 0K9
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Feb 11, 2026
Mar 19, 2026
$490,000
Affiliation: Canadian Institutes of Health Research
Address: 234 Laurier Ave West, Ottawa, ON K1A 0K9
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.